Nanosonics Company Description

Nanosonics Limited operates as an infection prevention company globally.

The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies.

Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform.

The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Nanosonics Limited

Country	Australia
Founded	2000
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	466
CEO	Michael Kavanagh

Contact Details

Address: Building A Macquarie Park, 2113 Australia
Phone	61 2 8063 1600
Website	nanosonics.com.au

Stock Details

Ticker Symbol	NAN
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000NAN9
SIC Code	3845

Key Executives

Name	Position
Michael C. Kavanagh BSc, M.B.A.	Chief Executive Officer, President, MD and Executive Director
Jason Burriss	Chief Financial Officer
Rod Lopez M.B.A.	Chief Operating Officer and Regional President for Asia Pacific
Sunny Pillai	Chief Information Officer
Jon Burdach Ph.D.	Chief Medical Affairs and Scientific Officer
Matthew Carbines B.Com., L.L.B.	General Counsel and Company Secretary
Matthew Lipscombe B.E., B.Sc., M.B.A.	Chief Marketing Officer
Jodi Sampson M.A.I.C.D., M.B.A.	Chief People and Culture Officer
Ken Shaw B.Sc.	Regional President of United States, Canada and Latin America
Ronan Wright B.E., B.Sc.	Regional President of Europe, Middle East and Africa (EMEA)